The Protective Effect for Liver Organ in Patients With Anti-TB Drugs Using of Acetylcysteine (NAC)

Clinical trial NCT02889757 · UNKNOWN

Trial details

NCT number: NCT02889757
Sponsor: Far Eastern Memorial Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Protective Effect in TB-DIH TB-DIH Means: Drug Induced Liver Function Abnormalities

Start date: 2017-01-01
Primary completion: 2018-12-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.